Alocane Plus
- Product NDC
- 68229-300
- 11-digit product format
- 682290300
- Labeler code
- 68229
- Product ID
- 68229-300_3a24dd33-2000-ccc2-e063-6394a90a8f13
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Lidocaine Hydrochloride and Benzalkonium Chloride
- Dosage form
- GEL
- Route
- TOPICAL
- Labeler
- Quest Products, Inc.
- Application
- M017
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2013-12-11
- Substance
- LIDOCAINE HYDROCHLORIDE; BENZALKONIUM CHLORIDE
- Active strength
- 4; .13 g/100mL; g/100mL
- Pharmacologic classes
- Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded product | product | 68229-300 | D | Discontinued by firm | 2026-11-19 | ||
| excluded package | package | 68229-300 | 68229-300-02 | D | Discontinued by firm | 2026-11-19 | |
| excluded package | package | 68229-300 | 68229-300-04 | D | Discontinued by firm | 2026-11-19 | |
| excluded package | package | 68229-300 | 68229-300-06 | D | Discontinued by firm | 2026-11-19 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Package NDC | Snapshot | Source SHA-256 |
|---|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | 68229-300-04 | d630ba8d3edf… | 732f749b63fb… |
| 2025-12-14 17:58 UTC · source 2025-12-05 | 68229-300-02 | d630ba8d3edf… | 732f749b63fb… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | 68229-300-04 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | 68229-300-02 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | 68229-300-02 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | 68229-300-02 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | 68229-300-02 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | 68229-300-02 | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | 68229-300-02 | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | 68229-300-02 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | 68229-300-02 | 0efc9e666f02… | f202fb6c5f17… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | 68229-300-02 | ad56d346431e… | cc804d4bbf1e… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | 68229-300-02 | 367a005e9d99… | 383a685ebd0f… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | 68229-300-02 | 557ba5c1ecfa… | 9c80585c8c6e… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Alocane Plus
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| LIDOCAINE HYDROCHLORIDE | 4 g/100mL |
| BENZALKONIUM CHLORIDE | .13 g/100mL |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| V13007Z41A | Internal UNII lookup |
| F5UM2KM3W7 | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 24538037-1d74-48a0-b909-98ecc57651fe | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 070fbed5-7088-434a-a7ce-f2a64d8d40ac | Product name | 2 | 20260107 |
| bee66ce1-adb7-9d3b-67d9-582e4c54e80f | Product name | 5 | 20250819 |
| 860a93dc-4863-49cc-b284-6bbe8191bc48 | Product name | 4 | 20250214 |
| eaba870a-6a9d-442e-8643-87b3f558a451 | Product name | 1 | 20250117 |
| 9b4cf230-fd05-41d5-98c6-5db9ecb27b86 | Product name | 1 | 20230117 |
| 7d755fa1-1087-4dcd-98f0-6d4bba479a57 | Product name | 3 | 20210602 |
| aed701d5-9c75-dfaf-7154-cde46179faea | Product name | 9 | 20200313 |
| fa8b5901-e681-426f-82fe-54f6d81ec698 | Product name | 4 | 20180619 |
| 332d03e4-aa24-4b11-841a-02bf41081920 | Product name | 1 | 20171221 |
| c08ab52f-2fc8-4409-9d9f-ed8edc0bd070 | Product name | 1 | 20171221 |
| 68ed98f8-24c2-44a0-944a-6d36e82ce25a | Product name | 1 | 20141222 |
| 1cd42bc2-a430-c72b-636d-991b235fbf80 | Product name | 1 | 20140508 |
| 49fa150c-f0de-cce7-3d9c-993ed81c5698 | Product name | 1 | 20140508 |
| 4d7ae718-ed00-bae8-2abe-9eaec1eef7ff | Product name | 1 | 20140508 |
| 9137811f-f279-8640-5aeb-99fa2145d64d | Product name | 1 | 20140508 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 68229-300-02 | 2020-02-03 | C162847 | 48780-1 | 9d75b9d1-2b47-f424-e053-dadaa90a57ce | Alocane ® Plus |
| 68229-300-02 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d1-2b47-f424-e053-dadaa90a57ce | Alocane ® Plus |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68229-300-01 | Alocane Plus | 3.55 mL in 1 DOSE PACK | GEL | 3.55 | 10 | |
| 68229-300-02 | Alocane Plus | 50 in 1 BOX | GEL | 50 | 10 | |
| 68229-300-03 | Alocane Plus | 1 in 1 CARTON | GEL | 1 | 10 | |
| 68229-300-03 | Alocane Plus | 59 mL in 1 TUBE | GEL | 59 | 10 | |
| 68229-300-04 | Alocane Plus | 946 mL in 1 BOTTLE, PUMP | GEL | 946 | 10 | |
| 68229-300-05 | Alocane Plus | 3.55 mL in 1 DOSE PACK | GEL | 3.55 | 8 | |
| 68229-300-06 | Alocane Plus | 48 in 1 CARTON | GEL | 48 | 8 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 68229-300-01 | EA - Each | 68229-300 | 379cbe87-939f-4066-8e28-789c4c3430db | 1 | 2021-01-08 |
| 68229-300-02 | EA - Each | 68229-300 | b520af95-ef09-4734-9392-dcb3d85fe981 | 1 | 2021-01-08 |
| 68229-300-03 | ML - Milliliter | 68229-300 | 27207190-a638-4f5a-b3df-27cde1c29d3b | 1 | 2021-09-07 |
| 68229-300-04 | ML - Milliliter | 68229-300 | 74748392-6b14-42fc-8c52-9340ed8a8bb3 | 1 | 2021-09-07 |
| 68229-300-05 | ML - Milliliter | 68229-300 | e75b92b2-0797-472a-8c2e-1f676e76b8ff | 2 | 2022-02-07 |
| 68229-300-06 | ML - Milliliter | 68229-300 | 110ad54a-6f0b-4007-9433-4a41ec8d3543 | 2 | 2022-02-07 |
DailyMed Socrata Ingredients#
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 68229-300 | ALOCANE PLUS (LIDOCAINE HYDROCHLORIDE AND BENZALKONIUM CHLORIDE) GEL [QUEST PRODUCTS, INC.] | 9 | Current NDC, Legacy NDC, 5 package rows | 20240110_24538037-1d74-48a0-b909-98ecc57651fe.zip |
| 68229-300 | ALOCANE PLUS (LIDOCAINE HYDROCHLORIDE AND BENZALKONIUM CHLORIDE) GEL [QUEST PRODUCTS LLC] | 7 | Current NDC, Legacy NDC, 2 package rows | 20241107_b3ec09b9-7511-0895-e053-2a95a90a7840.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Westlake Itch Relief | DIPHENHYDRAMINE HCL, ZINC ACETATE | Westlake HB Pharma LLC | 0c416ba6-b01f-0609-e063-6294a90ae2a1 | 2023-12-11 | Warnings | M017 |
| CVS Regular Strength Itch Stopping | DIPHENHYDRAMINE HYDROCHLORIDE, ZINC ACETATE | CVS | 87473ace-d834-e43f-e053-2a95a90a819c | 2023-12-11 | Warnings | M017 |
| Katinko External Analgesic Oil | CAMPHOR (SYNTHETIC), MENTHOL, METHYL SALICYLATE | Greenstone Pharmaceutical Inc. | 5881fc35-3293-4f0b-801a-afcd6feb9496 | 2023-12-08 | Warnings | M017 |
| Katinko Pain And Itch Relieving | CAMPHOR (SYNTHETIC), MENTHOL, METHYL SALICYLATE | Greenstone Pharmaceutical Inc. | fe907fa4-4a01-4974-b71f-9cd980b4eaa2 | 2023-12-08 | Warnings, Adverse reactions | M017 |
| Cycle | MENTHOL | La Mend, Inc. | cfc0bcde-ef91-1e6c-e053-2a95a90ab79e | 2023-12-07 | Warnings | M017 |
| Hemorrhoidal Pain Relief Cream | GLYCERIN, PHENYLEPHRINE HCL, PRAMOXINE HCL, WHITE PETROLATUM | WALGREENS | 03bbe146-f185-bcfa-e063-6394a90a85bf | 2023-12-04 | Warnings | M017 |
| TACT | DIPHENHYDRAMINE HYDROCHLORIDE, MENTHOL | Sato Pharmaceutical Inc., Ltd. | b6e2ee24-69de-4dfd-9081-b9537b7a7bad | 2023-12-04 | Warnings | M017 |
| Overnight Cold Therapy Pain Relief | MENTHOL, UNSPECIFIED FORM | Walgreen Co. | 2cbd0966-4cf9-4271-bd53-6672b1ed2a99 | 2023-12-04 | Warnings | M017 |
| Prolayed Lidocaine Male Genital Desensitizer | LIDOCAINE | ViaDerma Distribution, Inc. | 9c5ad0d0-ca7a-4321-9334-f06f3f6be18f | 2023-12-02 | Warnings | M017 |
| Liberdol Topical Analgesic | METHYL SALICYLATE, MENTHOL, CAMPHOR (SYNTHETIC) | ViaDerma Distribution, Inc | ab52cd0e-34fa-41c7-9ce7-1183c2aff8d8 | 2023-12-01 | Warnings | M017 |
| Prolayed | LIDOCAINE | MATRIX MIXOLOGY, INC | ae317876-adb1-6d13-e053-2995a90a74af | 2023-12-01 | Warnings | M017 |
| Tact Cool Jelly | DIPHENHYDRAMINE HYDROCHLORIDE, LEVOMENTHOL | Sato Pharmaceutical Co., Ltd. | f34872c9-91b9-49db-8e41-5b54a069284a | 2023-12-01 | Warnings | M017 |
| Satohap | METHYL SALICYLATE, DL-CAMPHOR, L-MENTHOL | Sato Pharmaceutical Co., Ltd. | 348fde05-2797-4410-a1b2-99e64187c4fe | 2023-12-01 | Warnings | M017 |
| Menthozen Hydrogel | MENTHOL, CAPSAICIN | Proficient Rx LP | 85a7809e-c43f-4138-a85b-44e1b586def5 | 2023-12-01 | Warnings | M017 |
| Menthozen Cream | METHYL SALICYLATE, MENTHOL, CAPSAICIN | Proficient Rx LP | 66681906-c5f5-4c57-bb43-9c83cccc0062 | 2023-12-01 | Warnings | M017 |
| Lidozen Patch | LIDOCAINE, MENTHOL | Proficient Rx LP | c0df4b8b-2679-4652-9144-a8db916a186b | 2023-12-01 | Warnings | M017 |
| Lidozen Gel | LIDOCAINE HYDROCHLORIDE, MENTHOL | Proficient Rx LP | 7c300dec-cefd-4b79-a948-a917b7708a04 | 2023-12-01 | Warnings | M017 |
| Menthozen | METHYL SALICYLATE, MENTHOL, CAPSAICIN | Proficient Rx LP | 2adf3c4d-636f-4e02-b501-946b4df5f5d6 | 2023-12-01 | Warnings | M017 |
| Lidozen | LIDOCAINE, MENTHOL | Proficient Rx LP | 488d665c-a4fe-4a69-bab3-34b2347f4b05 | 2023-12-01 | Warnings | M017 |
| Thera Plus Max Strength Lidocaine Pain Relief Liquid | LIDOCAINE HYDROCHLORIDE | Fourstar Group USA, Inc. | 0a228b06-0e1c-6c75-e063-6294a90a9a0e | 2023-11-30 | Warnings | M017 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 2587646 | ALOCANE plus 4 % / 0.13 % Topical Gel | PSN | 24538037-1d74-48a0-b909-98ecc57651fe | 10 |
| 2375042 | benzalkonium chloride 0.13 % / lidocaine hydrochloride 4 % Topical Gel | PSN | 24538037-1d74-48a0-b909-98ecc57651fe | 10 |
| 2587646 | benzalkonium chloride 0.0013 MG/MG / lidocaine hydrochloride 0.04 MG/MG Topical Gel [Alocane Plus] | SBD | 24538037-1d74-48a0-b909-98ecc57651fe | 10 |
| 2375042 | benzalkonium chloride 0.0013 MG/MG / lidocaine hydrochloride 0.04 MG/MG Topical Gel | SCD | 24538037-1d74-48a0-b909-98ecc57651fe | 10 |
| 2587646 | Alocane Plus (benzalkonium chloride 0.13 % / lidocaine hydrochloride 4 % ) Topical Gel | SY | 24538037-1d74-48a0-b909-98ecc57651fe | 10 |
| 2375042 | benzalkonium chloride 0.13 % / lidocaine hydrochloride 4 % Topical Gel | SY | 24538037-1d74-48a0-b909-98ecc57651fe | 10 |
| 2587646 | ALOCANE plus 4 % / 0.13 % Topical Gel | PSN | b3ec09b9-7511-0895-e053-2a95a90a7840 | 8 |
| 2375042 | benzalkonium chloride 0.13 % / lidocaine hydrochloride 4 % Topical Gel | PSN | b3ec09b9-7511-0895-e053-2a95a90a7840 | 8 |
| 2587646 | benzalkonium chloride 0.0013 MG/MG / lidocaine hydrochloride 0.04 MG/MG Topical Gel [Alocane Plus] | SBD | b3ec09b9-7511-0895-e053-2a95a90a7840 | 8 |
| 2375042 | benzalkonium chloride 0.0013 MG/MG / lidocaine hydrochloride 0.04 MG/MG Topical Gel | SCD | b3ec09b9-7511-0895-e053-2a95a90a7840 | 8 |
| 2587646 | Alocane Plus (benzalkonium chloride 0.13 % / lidocaine hydrochloride 4 % ) Topical Gel | SY | b3ec09b9-7511-0895-e053-2a95a90a7840 | 8 |
| 2375042 | benzalkonium chloride 0.13 % / lidocaine hydrochloride 4 % Topical Gel | SY | b3ec09b9-7511-0895-e053-2a95a90a7840 | 8 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 68229-300-01 | 68229030001 | 3.55 mL in 1 DOSE PACK | 3.55 ml | Historical | ||||
| 68229-300-02 | 68229030002 | 50 DOSE PACK in 1 BOX (68229-300-02) > 3.55 mL in 1 DOSE PACK (68229-300-01) | 50 dose pack | 2013-12-11 | 0000-00-00 | No | No | Current |
| 68229-300-03 | 68229030003 | 1 TUBE in 1 CARTON (68229-300-03) / 59 mL in 1 TUBE | 1 tube | 2020-03-01 | 0000-00-00 | No | No | Current |
| 68229-300-04 | 68229030004 | 946 mL in 1 BOTTLE, PUMP (68229-300-04) | 946 ml | 2021-07-09 | 0000-00-00 | No | No | Current |
| 68229-300-05 | 68229030005 | 3.55 mL in 1 DOSE PACK | 3.55 ml | Historical | ||||
| 68229-300-06 | 68229030006 | 48 DOSE PACK in 1 CARTON (68229-300-06) > 3.55 mL in 1 DOSE PACK (68229-300-05) | 48 dose pack | 2020-11-12 | 0000-00-00 | No | No | Current |